Kintara Therapeutics Inc
(NASDAQ:KTRA)
$0.3605
-0.0148[-3.94%]
Last update: 9:21AM (Delayed 15-Minutes)
Get Real Time Here
$0.3605
0[0.00%]
After-Hours
Open0.380Close-
Vol / Avg.167.784K / 424.976KMkt Cap629.580K
Day Range0.350 - 0.38052 Wk Range0.315 - 15.450

Kintara Therapeutics Stock (NASDAQ:KTRA), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$14.00

Lowest Price Target1

$14.00

Consensus Price Target1

$5.50

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
30100

Analyst Firms Making Recommendations1

  • Maxim Group
  • Dawson James
  • HC Wainwright & Co.
  • Aegis Capital

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Kintara Therapeutics

Upgrades (1)

Downgrades (2)

Initiations (1)

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
07/14/2023KTRABuy Now
Kintara Therapeutics
$0.363799.72%Maxim Group
Jason McCarthy
→ $14UpgradeHold → BuyGet Alert
09/29/2022KTRABuy Now
Kintara Therapeutics
$0.36Maxim Group
Jason McCarthy
DowngradeBuy → HoldGet Alert
05/16/2022KTRABuy Now
Kintara Therapeutics
$0.36Dawson James
Jason Kolbert
DowngradeBuy → NeutralGet Alert
01/20/2022KTRABuy Now
Kintara Therapeutics
$0.36735.65%HC Wainwright & Co.
Michael King
$300 → $150MaintainsBuyGet Alert
09/30/2021KTRABuy Now
Kintara Therapeutics
$0.361292.76%Aegis Capital
Nathan Weinstein
MaintainsBuyGet Alert
09/28/2021KTRABuy Now
Kintara Therapeutics
$0.361571.31%HC Wainwright & Co.
Michael King
Initiates → BuyGet Alert
02/03/2021KTRABuy Now
Kintara Therapeutics
$0.361849.86%Aegis Capital
Nathan Weinstein
MaintainsBuyGet Alert
Q

What is the target price for Kintara Therapeutics (KTRA)?

A

The latest price target for Kintara Therapeutics (NASDAQ: KTRA) was reported by Maxim Group on July 14, 2023. The analyst firm set a price target for $14.00 expecting KTRA to rise to within 12 months (a possible 3783.50% upside). 1 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Kintara Therapeutics (KTRA)?

A

The latest analyst rating for Kintara Therapeutics (NASDAQ: KTRA) was provided by Maxim Group, and Kintara Therapeutics upgraded their buy rating.

Q

When is the next analyst rating going to be posted or updated for Kintara Therapeutics (KTRA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kintara Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kintara Therapeutics was filed on July 14, 2023 so you should expect the next rating to be made available sometime around July 14, 2024.

Q

Is the Analyst Rating Kintara Therapeutics (KTRA) correct?

A

While ratings are subjective and will change, the latest Kintara Therapeutics (KTRA) rating was a upgraded with a price target of $0.00 to $14.00. The current price Kintara Therapeutics (KTRA) is trading at is $0.36, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.